PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
WAI CHUN BIOTEC (0660.HK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

KYG9450C1024

Sector

Basic Materials

Industry

Chemicals

IPO Date

Feb 5, 1993

Highlights

Market Cap

HK$12.52M

Year Range

HK$0.06 - HK$0.18

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of HK$10,000 in WAI CHUN BIOTEC, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-40.00%-30.00%-20.00%-10.00%0.00%10.00%SeptemberOctoberNovemberDecember2025February
-26.83%
8.97%
0660.HK (WAI CHUN BIOTEC)
Benchmark (^GSPC)

Returns By Period

WAI CHUN BIOTEC had a return of 10.61% year-to-date (YTD) and -51.66% in the last 12 months. Over the past 10 years, WAI CHUN BIOTEC had an annualized return of -46.48%, while the S&P 500 had an annualized return of 11.33%, indicating that WAI CHUN BIOTEC did not perform as well as the benchmark.


0660.HK

YTD

10.61%

1M

-23.16%

6M

-27.00%

1Y

-51.66%

5Y*

-62.52%

10Y*

-46.48%

^GSPC (Benchmark)

YTD

3.96%

1M

1.97%

6M

10.09%

1Y

22.16%

5Y*

12.70%

10Y*

11.33%

*Annualized

Monthly Returns

The table below presents the monthly returns of 0660.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202528.79%10.61%
20244.86%-4.64%-7.64%-24.81%22.00%2.46%-20.00%-13.00%-14.94%0.00%0.00%-10.81%-54.17%
20237.14%-20.00%6.67%-14.06%-9.09%2.00%-1.96%-3.00%-5.15%54.35%14.79%-11.66%2.86%
2022-10.71%-16.00%2.38%-20.93%2.94%14.29%-5.00%-5.26%27.78%-36.96%3.45%-53.33%-75.00%
2021-22.22%28.57%0.00%-12.35%5.63%-1.33%-9.46%-5.97%-14.29%18.52%-17.19%5.66%-30.86%
2020-16.67%20.00%-16.67%-3.33%-24.14%-27.27%-18.75%-23.08%-19.00%-0.00%-77.50%
201935.48%-2.38%9.76%-4.44%16.28%-10.00%2.22%-2.17%-4.44%-4.65%-4.88%-7.69%16.13%
2018-13.24%13.56%-17.91%9.09%-8.33%20.00%6.06%0.00%-12.86%11.48%-4.41%-52.31%-54.41%
20174.88%2.33%1.14%-4.49%-12.94%6.76%1.27%-5.00%3.95%-6.33%-10.81%3.03%-17.07%
2016-40.30%170.00%4.63%-5.31%22.43%19.08%-30.13%-0.92%-0.93%-16.82%-6.74%-1.20%22.39%
2015143.86%-13.67%-18.33%56.12%0.65%5.84%-29.45%-27.83%7.23%-4.49%-11.76%-10.67%17.54%
20140.00%16.28%2.00%-1.96%-10.00%6.67%12.50%-9.26%-4.08%-4.26%11.11%14.00%32.56%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of 0660.HK is 17, meaning it’s performing worse than 83% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of 0660.HK is 1717
Overall Rank
The Sharpe Ratio Rank of 0660.HK is 2020
Sharpe Ratio Rank
The Sortino Ratio Rank of 0660.HK is 2121
Sortino Ratio Rank
The Omega Ratio Rank of 0660.HK is 1515
Omega Ratio Rank
The Calmar Ratio Rank of 0660.HK is 1515
Calmar Ratio Rank
The Martin Ratio Rank of 0660.HK is 1414
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for WAI CHUN BIOTEC (0660.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for 0660.HK, currently valued at -0.48, compared to the broader market-2.000.002.004.00-0.481.83
The chart of Sortino ratio for 0660.HK, currently valued at -0.43, compared to the broader market-6.00-4.00-2.000.002.004.006.00-0.432.47
The chart of Omega ratio for 0660.HK, currently valued at 0.91, compared to the broader market0.501.001.502.000.911.33
The chart of Calmar ratio for 0660.HK, currently valued at -0.52, compared to the broader market0.002.004.006.00-0.522.76
The chart of Martin ratio for 0660.HK, currently valued at -1.19, compared to the broader market-10.000.0010.0020.0030.00-1.1911.27
0660.HK
^GSPC

The current WAI CHUN BIOTEC Sharpe ratio is -0.48. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of WAI CHUN BIOTEC with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.48
1.78
0660.HK (WAI CHUN BIOTEC)
Benchmark (^GSPC)

Dividends

Dividend History


WAI CHUN BIOTEC doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-99.90%
-0.13%
0660.HK (WAI CHUN BIOTEC)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the WAI CHUN BIOTEC. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the WAI CHUN BIOTEC was 99.92%, occurring on Dec 27, 2024. The portfolio has not yet recovered.

The current WAI CHUN BIOTEC drawdown is 99.90%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.92%Aug 19, 20083285Dec 27, 2024
-54.25%Jul 17, 200751Sep 27, 2007200Aug 14, 2008251
-31.19%Jun 4, 200711Jun 18, 20077Jun 28, 200718
-21.67%Apr 10, 20073Apr 12, 20073Apr 17, 20076
-16.67%Mar 19, 20077Mar 27, 20072Mar 30, 20079

Volatility

Volatility Chart

The current WAI CHUN BIOTEC volatility is 17.96%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%SeptemberOctoberNovemberDecember2025February
17.96%
3.17%
0660.HK (WAI CHUN BIOTEC)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of WAI CHUN BIOTEC over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for WAI CHUN BIOTEC.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab